Emerging Therapies in the Management of HR+, HER2- Metastatic Breast Cancer - Episode 4
Laura Huppert, MD, and Yara Abdou, MD, review approaches to repeat hormone receptor and HER2 status testing before initiating later lines of therapy in patients with metastatic breast cancer.